Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 30, 2022

Study Completion Date

November 30, 2022

Conditions
Obesity, MorbidInsulin Resistance
Interventions
BIOLOGICAL

Fecal filtrate from 150 g stool from healthy lean donors

150 g stool from healthy lean donors will be diluted in 0.9% normal saline to a total volume of 450 mL. Preparation from frozen stool.

BIOLOGICAL

Fecal filtrate from 150 g of the recipient's own stool

150 g stool from the recipient will be diluted in 0.9% normal saline to a total volume of 450 mL. Preparation from frozen stool.

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

MOUNT SINAI HOSPITAL

OTHER

collaborator

University of Toronto

OTHER

lead

Johane Allard

OTHER

NCT02970877 - Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients | Biotech Hunter | Biotech Hunter